Sinha, Sutapa
Secreto, Charla R.
Boysen, Justin C.
Lesnick, Connie
Wang, Zhiquan http://orcid.org/0000-0002-8243-7251
Ding, Wei http://orcid.org/0000-0001-9811-4601
Call, Timothy G.
Kenderian, Saad J. http://orcid.org/0000-0003-2767-3830
Parikh, Sameer A. http://orcid.org/0000-0002-3221-7314
Warner, Steven L.
Bearss, David J.
Ghosh, Asish K.
Kay, Neil E. http://orcid.org/0000-0002-5951-5055
Funding for this research was provided by:
AstraZeneca
TG Therapeutics
AbbVie Inc. | AbbVie Biotherapeutics
Tolero Pharma
Article History
Received: 2 October 2020
Revised: 22 January 2021
Accepted: 28 January 2021
First Online: 18 February 2021
Conflict of interest
: S.S., C.R.S., J.C.B., C.L., Z.W., T.G.C., and A.K.G.—No conflicts. S.L.W. and D.J.B.—Employed by Tolero, developer of TP-0903. S.J.K.—S.J.K. is an inventor on patents in the field of CART cell therapy that are licensed to Novartis, Humanigen, and Mettafore. S.J.K. receives research funding from Kite, Gilead, Juno, BMS, Morphosys, Sunesis, leahlabs, Lentigen, Humanigen, and Tolero. S.J.K. is on the DSMB of Humanigen. S.J.K. is on scientific advisory boards for Humanigen, Kite, and Juno. S.A.P.—Research funding has been provided to the institution from Pharmacyclics, MorphoSys, Janssen, AstraZeneca, TG Therapeutics, Bristol Myers Squibb, Merck, AbbVie, and Ascentage Pharma for clinical studies in which S.A.P. is a principal investigator. S.A.P. has also participated in Advisory Board meetings of Pharmacyclics, AstraZeneca, Genentech, Gilead, GlaxoSmithKline, Verastem Oncology, and AbbVie (he was not personally compensated for his participation). W.D.—Research funding from Merck, DTRM, Astrazeneca, and Abbvie, advisory board for Merck, Octapharma, MEI pharma, Alexion, and Beigene. N.E.K.—Abbvie, Astra Zeneca, Cytomx Therapy, Dava oncology, Juno Theraputics, Oncotracker, Pharmacyclics. DSMC (Data Safety Monitoring Committee) for: Agios Pharm, AstraZeneca, BMS-Celgene, Cytomx Therapeutics, Morpho-sys, Rigel. Research funding from: Abbvie, Acerta Pharma, Bristol Meyer Squib, Celgene, MEI Pharma, Pharmacyclics, Sunesis, TG Therapeutics, and Tolero Pharmaceuticals.